-- Acquisition of PCX Expands the Company's Footprint in Japan

Marken announced today the acquisition of PCX International Co. Ltd based in 
Japan.  PCX operates from their Tokyo headquarters to coordinate the delivery 
of over 3,000 clinical trial shipments per month.  This acquisition strengthens 
Marken's existing supply chain footprint in Japan which will add capacity for 
domestic and international clinical shipments. 

Logo - https://mma.prnewswire.com/media/732970/MARKEN_Logo.jpg 

PCX was founded in 2008 as a specialist courier serving the Japanese clinical 
trials industry. It has since established a reputation for high quality service 
with strong local provider and airline relationships. PCX manages over 200 
highly trained drivers covering the nation and currently provides collection 
and delivery services for Marken's existing company in Japan. The combination 
of PCX and Marken Japan KK will allow further operational flexibility, cost 
savings and process optimization. 

Wes Wheeler, Marken's Chief Executive Officer, commented, "The acquisition of 
PCX provides Marken with direct control of 200 specialist drivers and other 
partners in Japan.  The addition of this new network satisfies our need for a 
greater physical presence locally in Japan and provides a platform for more 
expansive services to the local clinical client base. We look forward to 
welcoming the PCX team to the Marken family and meeting with our clients to 
discuss their clinical supply chain needs."

About Marken 

Marken is a wholly owned subsidiary of UPS. Marken is the only patient-centric 
supply chain organization 100% dedicated to the pharmaceutical and life 
sciences industries. Marken maintains the leading position for Direct to 
Patient and Home Health care services, biological sample shipments and offers a 
state-of-the-art GMP-compliant depot network and logistic hubs in 51 locations 
worldwide for clinical trial material storage and distribution. Marken's more 
than 1000 staff members manage 70,000 drug and biological shipments every month 
at all temperature ranges in more than 150 countries. Additional services such 
as biological kit production, ancillary material sourcing, storage and 
distribution, shipment lane verification and qualifications, as well as GDP, 
regulatory and compliance consultancy add to Marken's unique position in the 
pharma and logistics industry. 

SOURCE: Marken

CONTACT: Christine Noble, info@marken.com, +1 919 474 6890, www.marken.com